939 1030
in older adults: the Cancer Prevention Study II Nutrition Cohort.
Cancer Epidemiol Biomarkers Prev 2004;13:2187–95.
[33]
Thorsen L, Courneya KS, Stevinson C, Fossa SD. A systematic review of physical activity in prostate cancer survivors: outcomes, preva- lence, and determinants. Support Care Cancer 2008;16:987–97.
[34]
Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH. An update of controlled physical activity trials in cancer survivors: a system- atic review and meta-analysis. J Cancer Surviv 2010;4:87–100.[35]
Bourke L, Smith D, Steed L, et al. Exercise for men with prostate cancer: a systematic review and meta-analysis. Eur Urol 2016;69:693–703.[36]
University of California, San Francisco. Active Surveillance Exercise Clinical Trial (ASExerciseRCT). Bethesda, MD: National Library of Medicine; 2000,, ClinicalTrials.gov. https://clinicaltrials.gov/show/ NCT02435472 (NLM identifier: NCT02435472).[37]
Sheffield Teaching Hospitals NHS Foundation Trust. Exercise Training as a Novel Primary Therapy for Men with Localised Prostate Cancer (PANTERA). Bethesda, MD: National Library of Medicine; 2000,, Clin- icalTrials.gov. https://clinicaltrials.gov/show/NCT02409212 (NLM identifier: NCT02409212).
[38]
Vancouver Prostate Centre. Feasibility ofMeasuring Exercise’s Effects on molecular Mechanisms of Disease Progression in Prostate Cancer (EMMPC). Bethesda, MD: National Library of Medicine; 2000,, Clin- icalTrials.gov. https://clinicaltrials.gov/show/NCT02481648 (NLM identifier: NCT02481648).[39]
Movember Foundation. INTense Exercise foR surVivAL Among Men With Metastatic Castrate-Resistant Prostate Cancer (INTERVAL). Bethesda, MD: National Library of Medicine; 2000,, ClinicalTrials.- gov. https://clinicaltrials.gov/ct2/show/study/NCT02730338 (NLM identifier: NCT02730338).E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 9 3 1 – 9 3 9
939